Alpha Wealth Funds’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$471K 40
2024
Q4
$471K Buy
+20,000
New +$492K 0.45% 31

Other funds holding ARKG

Alpha Wealth Funds's ARKG Position: Q1 2025 in Review

Alpha Wealth Funds sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 20,000 shares — an estimated $471K sold.

Alpha Wealth Funds first reported a position in ARKG in Q4 2024 and held it in 1 quarter. The position peaked at $471K in Q4 2024. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Alpha Wealth Funds reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Alpha Wealth Funds sold 20,000 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $471K.
  • Alpha Wealth Funds first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 1 quarter.
  • Alpha Wealth Funds's ARK Genomic Revolution ETF position peaked at $471K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Alpha Wealth Funds's 13F filing for Q1 2025, filed 10 Apr 2025.